Today’s top gainers include the company Illumina Inc. (NASDAQ:ILMN) which is in the industry Biotechnology, gaining 0.94% today. In the last week its performance is 5.12%, and -14.72% for the past quarter. Currently, Illumina Inc., ILMN has a target price of 153.9, so today’s gain of 0.94% is a significant step towards its target price. The GAP today is therefore 1.08%.
Illumina Inc. (NASDAQ:ILMN), has a market cap of 21489.69, and is based in USA. Insider ownership is at 1.20%, and institutional ownership is 96.70%.
At the current price of 147.23, it has a dividend yield of *TBA, and its target price is 153.9. This is with a profit margin of 18.40%, and total debt/equity of 0.51. Illumina Inc. (NASDAQ:ILMN) has a P/E of 52.94, as well as a forward P/E of 36.95.
With a current EPS of 2.78, and a forecasted EPS growth for next year at 18.07%,Illumina Inc. (NASDAQ:ILMN) has had a EPS growth for the past five years at 28.90%. For the next five years EPS growth is projected to be 15.80%.
Performance for the year is -35.73%. Since its IPO date on 7/28/2000, the total performance to date is -23.30%.
Volume today for Illumina Inc. (NASDAQ:ILMN), is 655400, while its average volume is 1449.91. Whilst the total gain today was 0.94%, it did have a day high of -1.52%.
Volatility for this week has been at 2.86%, and 2.96% for the month. The 52-week low for Illumina Inc., ILMN has been 15.84%, while the 52-week-high has reached -39.25%.
Looking at its return of investments, which is 16.60%, and its return on assets is 11.10%. Illumina Inc. (NASDAQ:ILMN) has an operating margin of 24.80%. With a sales growth of 6.20% quarter over quarter. Bearing in mind that Illumina Inc., ILMN is in the sector Healthcare, its long-term debt/equity is 0.51, and has a current ratio of 4.3 and 3.7 for quick ratio.
So what is the value of Illumina Inc.? Well its PEG is 3.35, and the P/S is 9.54, along with a P/B of 10.86. Meanwhile it has a p/cash of 16.